Please contact: Liz MacMaster, firstname.lastname@example.org, 613-238-4075, ext. 261 if you have any questions, or require additional information.
To promote the exchange of ideas and information on perioperative care between specialties
Participants will benefit by being better able to:
- Identify strategies for perioperative cardiac risk assessment;
- Review recent data on new perioperative prognostic biomarkers;
- Appraise the data on perioperative anti-platelet use;
- Examine and discuss perioperative management of cardiac devices;
- Assess management of perioperative atrial fibrillation;
- Update global perioperative care and outcomes;
- Appraise new data on intraoperative fluid and blood pressure management;
- Discuss perioperative diabetes management; and
- Debate current controversies in perioperative medicine: arrhythmia’s and anti coagulation and intraoperative supplemental oxygen therapy.
We are in the process of applying for accreditation for Section 1 credits. Please submit your Session Information (Word file) by February 15, 2018 to email@example.com
Requirement for presenters – will need to review and conform with:
CMA Guidelines for Physicians in Interactions With Industry
Innovative Medicines Canada, 2016 Code of Ethical Practices
- Use interactive teaching techniques for at least 25% of the session time
- Summarize and cite relevant research publications / evidence base
- Do not feel that you must cover the topic comprehensively
- Ensure the presentation fits comfortably into the allotted time and remains relevant to the audience
- Focus on the proposed objectives
- Contact the course chair with any proposed title or objectives changes
- Generic names should be used on all presentations and written materials. If trade names are used they should be accompanied by the generic name.
- Recommendations must be supported with high-quality evidence (meta-analyses/systematic review of RCTs or well-designed cohort studies)
- Include references in the relevant slides / sections in teaching materials (slides or handouts)
- Acknowledge when there is no evidence to support assertions or recommendations
- Provide a rationale if using only one study, or a limited selection from available studies
- Include discussion about commonly encountered barriers to practice change
- Do not alter evidence to highlight one treatment or product
- Both potential harms and benefits should be discussed (e.g. presenting the number needed to treat and number need to harm)
Medical expert: knowledge, clinical and/or procedural skills required for effective patient centered care.
Communicator: effective doctor/patient relationships.
Collaborator: working effectively within a health care team.
Leader: contributes to a vision of a high-quality health care system and takes responsibility for the delivery of excellent patient care through their activities as clinicians, administrators, scholars, or teachers.
Health Advocate: developing expertise and influence to advocate for the health and well-being of patients, communities and/or populations.
Scholar: lifelong reflective learning as well as creating, disseminating, applying and translating medical knowledge.
Professional: the health and well-being of individuals and society through ethical practice, adherence to professional regulations and personal high standards of care.
CONFLICT OF INTEREST
A Conflict of Interest may occur in situations where the personal and professional interests of individuals may have actual, potential or apparent influence over their judgement and actions. The intent of this disclosure requirement is to inform the audience of any bias that speakers may have, not to prohibit speakers from presenting.
What to disclose: All financial or ‘in kind’ relationships (not only those relevant to the subject being discussed) encompassing the previous two (2) years must be disclosed.
“It is the presenter’s responsibility to ensure the scientific validity, objectivity, and completeness of CPD/CME activities. Organizers and individual presenters must disclose to the participants at their CPD/CME events any financial affiliations with manufacturers of products mentioned at the event, or with manufacturers of competing products.”
Presenters must ensure their presentations, and any recommendations, are balanced and reflect the current scientific literature. Unapproved use of products or services must be declared within the presentation. The only caveat to this guideline is where there is only one treatment or management strategy. Examples of relationships that must be disclosed include but are not limited to the categories detailed over the page.
How to disclose
Please complete the Conflict of Interest Form and submit it to firstname.lastname@example.org
Royal College of Physicians and Surgeons of Canada requires that disclosures are made either in the form of a slide, verbally, or by inclusion in written conference materials. Speakers who have no involvement with industry should inform the audience that they cannot identify any conflict of interest and include this declaration in their slides or written material. If a disclosure slide has not been included in a presentation, it must be inserted by the Planning Committee.
Failure to disclose, or false disclosure, may require the Planning Committee to replace the speaker. If you have any questions regarding conflict of interest disclosure when preparing your CME/CPD presentations, please contact your Planning Committee.
DISCLOSURE POWERPOINT SLIDES
Will be added shortly
 CMA Policy: Guidelines for physicians in Interactions with Industry. Approved 2007-Dec-01. http://policybase.cma.ca/dbtw-wpd/Policypdf/PD08-01.pdf